Gerresheimer Faces Potential Removal from SDAX Index

Gerresheimer's accounting errors delay financials, triggering imminent SDAX exclusion, BaFin probe, and loan talks. Stock down 73% from high.

Mounting accounting issues at packaging specialist Gerresheimer have escalated, now directly threatening the company's position on Germany's SDAX index. The certified financial statements for 2025 will not be available by the end of March, triggering an imminent exclusion from the index. Audited results are not expected before June.

A Cascade of Consequences from Accounting Errors

The root of the current turmoil lies in misapplied accounting for specific "bill-and-hold" agreements. Revenue and corresponding costs were recognized incorrectly, constituting a breach of International Financial Reporting Standards (IFRS). Germany's financial regulator, BaFin, initiated a special audit in September 2025 and expanded its probe in early March 2026 following the discovery of further accounting irregularities. In addition to KPMG, Grant Thornton is now also reviewing the financial statements for 2024 and 2025.

The ripple effects are significant. The release of first-quarter 2026 results and the Annual General Meeting scheduled for June 3 have both been postponed. Concurrently, the company is in discussions with its lenders to extend credit terms. A failure to secure these extensions could allow banks to exercise contractual rights. Gerresheimer also anticipates non-cash impairment charges totaling between 220 and 240 million euros. These are primarily linked to technology projects at Sensile Medical AG and the Moulded-Glass facility in Chicago Heights, which is slated for closure at the end of 2026.

Shareholder Landscape: A Mix of Short Sellers and New Buyers

The shareholder base presents a divided picture. The Deutsche Schutzvereinigung für Wertpapierbesitz (DSW), a German shareholder association, is examining potential claims for damages. On the other hand, new investments have been disclosed at the depressed share price level by the CastleKnight Master Fund and Deka Investment. Meanwhile, a prominent hedge fund increased its short position to 0.62% of the company's share capital on March 11.

The looming SDAX exclusion is likely to force index-tracking funds to rebalance their portfolios, creating additional selling pressure. The stock temporarily plunged by as much as 18% on March 19, leaving its price approximately 73% below its 52-week high from March 2025.

Until the audited financial statements are presented in June 2026, the ongoing BaFin investigations and the outcome of loan negotiations remain the central uncertainties. For the current fiscal year, Gerresheimer has provided a revenue forecast of 2.3 to 2.4 billion euros. However, the reliability of this guidance can only be assessed once verified figures are available.